secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2023-11-27T23:59:59+00:00
Accession:  0001558370-23-019325
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health receives second 180-day Nasdaq compliance period for bid price deficiency
--------------------------------------------------------------------------------

- Company failed to regain minimum $1 bid price by Nov 20, 2023 initial deadline.
- Nasdaq grants additional period until May 20, 2024 to cure the deficiency.
- Company may effect a reverse stock split if needed, no later than 10 business days before deadline.
- No immediate impact on common stock listing or trading at this time.
- Failure to cure by May 20, 2024 could lead to delisting and potential appeal to Nasdaq Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023019325/0001558370-23-019325-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023019325/nutx-20231121x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-019325

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer